12 research outputs found
S1292 Role of EUS-FNA Based Cytology in Differentiating Mucinous Versus Non-Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis
No full textRole of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis
Full text link
Su1021 Use of Oral Bisphosphonates and Risk of Colorectal Cancer: A Systemic Review and Meta-Analysis
No full textConstipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma
No full text
Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
No full textSafe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy
No full textPredictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy
No full textTo identify predictors of hypothyroidism after chemoradiation therapy for Hodgkin lymphoma (HL) and to compare outcomes after intensity modulated radiation therapy (IMRT) with those after 3-dimensional (3D) conformal radiation therapy (CRT)
Meeting Inpatient Glycemic Targets through Increased use of Basal Bolus Insulin Therapy
Get PDFThe implementation of IDS tool, which is integrated in the Epic, can assist providers in placing appropriate BBI insulin orders. Increased use of BBI use can result in reduction in hyperglycemia and hypoglycemia which can enhances overall patient safety and outcomes. Expanding or standardizing the intervention to other areas can help change prescriber practice and better glycemic control. Provider involvement and interest is an important factor in the utilization of the IDS tool.
Sigi Varghese pictured.https://openworks.mdanderson.org/aprn-week-21/1010/thumbnail.jp
